These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11950484)

  • 21. Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome.
    Bolte AC; van Eyck J; Kanhai HH; Bruinse HW; van Geijn HP; Dekker GA
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):371-7. PubMed ID: 9988803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketanserin in essential hypertension: a double-blind, placebo-controlled study.
    Cameron HA; Ramsay LE
    Postgrad Med J; 1985 Jul; 61(717):583-6. PubMed ID: 3161013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrapartum treatment of preeclamptic hypertension by ketanserin.
    Hulme VA; Odendaal HJ
    Am J Obstet Gynecol; 1986 Aug; 155(2):260-3. PubMed ID: 2943161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects during therapy with the serotonin antagonist ketanserin.
    Distler A
    Clin Physiol Biochem; 1990; 8 Suppl 3():64-80. PubMed ID: 1983424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
    Vermillion ST; Scardo JA; Newman RB; Chauhan SP
    Am J Obstet Gynecol; 1999 Oct; 181(4):858-61. PubMed ID: 10521742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [General treatment principles and antihypertensive therapy in pregnancy-induced hypertension, pre-eclampsia and eclampsia].
    Lechner W
    Gynakol Rundsch; 1991; 31(4):233-5. PubMed ID: 1794725
    [No Abstract]   [Full Text] [Related]  

  • 27. 24-hour blood pressure monitoring to evaluate the effects of nifedipine in pre-eclampsia and in chronic hypertension in pregnancy.
    Benedetto C; Zonca M; Giarola M; Maulà V; Chiarolini L; Carandente F
    Br J Obstet Gynaecol; 1997 Jun; 104(6):682-8. PubMed ID: 9197871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of hypertension in pregnancy.
    Michael CA
    Aust Fam Physician; 1978 Sep; 7(9):1113-7. PubMed ID: 736851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil].
    Wacker J; Müller J; Grischke EM; Unkels R; Bastert G
    Zentralbl Gynakol; 1994; 116(5):271-3. PubMed ID: 8023622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of hypertension in pregnancy.
    Chung NA; Beevers DG; Lip GY
    Am J Cardiovasc Drugs; 2001; 1(4):253-62. PubMed ID: 14728025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.
    Elatrous S; Nouira S; Ouanes Besbes L; Marghli S; Boussarssar M; Sakkouhi M; Abroug F
    Intensive Care Med; 2002 Sep; 28(9):1281-6. PubMed ID: 12209278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1135-41. PubMed ID: 26259808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intravenous ketanserin on severely hypertensive patients with double-blind crossover assessment of central side-effects.
    Jennings AA; Opie LH
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):120-4. PubMed ID: 2434787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension in pregnancy. A study of 142 women presenting before 32 weeks' gestation.
    Horvath JS; Korda A; Child A; Henderson-Smart D; Phippard A; Duggin GG; Hall BM; Tiller DJ
    Med J Aust; 1985 Jul; 143(1):19-21. PubMed ID: 4010599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
    Milei J; Lemus J; Bernardiner E
    Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia.
    Shi DD; Yang FZ; Zhou L; Wang N
    J Clin Pharm Ther; 2016 Dec; 41(6):657-661. PubMed ID: 27578562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension in pregnancy.
    Barton JR
    Ann Emerg Med; 2008 Mar; 51(3 Suppl):S16-7. PubMed ID: 18191290
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral beta-blockers for mild to moderate hypertension during pregnancy.
    Magee LA; Duley L
    Cochrane Database Syst Rev; 2000; 2003(4):CD002863. PubMed ID: 11034777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketanserin alone and in combination with enalapril in the treatment of essential hypertension: assessment of the haemodynamic effects.
    de Divitiis O; Galderisi M; Celentano A; Tammaro P; Garofalo M; Palmieri V; Crivaro M; Assogna G; Zanna C
    J Int Med Res; 1993; 21(3):113-25. PubMed ID: 8299854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy.
    Moodley J; Gouws E
    Br J Obstet Gynaecol; 1992 Sep; 99(9):727-30. PubMed ID: 1420010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.